Skip to main content

Articles

Page 276 of 329

  1. The cellular response of malignant tumors to hypoxia is diverse. Several important endogenous metabolic markers are upregulated under hypoxic conditions. We examined the staining patterns and co-expression of ...

    Authors: Saskia E Rademakers, Jasper Lok, Albert J van der Kogel, Johan Bussink and Johannes HAM Kaanders
    Citation: BMC Cancer 2011 11:167
    Content type: Research article Published on:

  2. Partnership for Health-2 (PFH-2) is a web-based version of Partnership for Health, an evidence-based smoking cessation intervention for childhood cancer survivors. This paper describes the PFH-2 intervention a...

    Authors: Janet S de Moor, Elaine Puleo, Jennifer S Ford, Mark Greenberg, David C Hodgson, Vida L Tyc, Jamie Ostroff, Lisa R Diller, Andrea Gurmankin Levy, Kim Sprunck-Harrild and Karen M Emmons
    Citation: BMC Cancer 2011 11:165
    Content type: Research article Published on:

  3. Gastric and esophageal cancers are among the most lethal human malignancies. Their epidemiology is geographically diverse. This study compares the survival of gastric and esophageal cancer patients among sever...

    Authors: Morteza Bashash, T Greg Hislop, Amil M Shah, Nhu Le, Angela Brooks-Wilson and Chris D Bajdik
    Citation: BMC Cancer 2011 11:164
    Content type: Research article Published on:

  4. Family size and birth order are known to influence the risk of some cancers. However, it is still unknown whether these effects change from early to later adulthood. We used the data of the Swedish Family-Canc...

    Authors: Melanie Bevier, Marianne Weires, Hauke Thomsen, Jan Sundquist and Kari Hemminki
    Citation: BMC Cancer 2011 11:163
    Content type: Research article Published on:

  5. Stromal fibroblasts participate in the development of a permissive environment for tumor growth, yet molecular pathways to therapeutically target fibroblasts are poorly defined. CD248, also known as endosialin...

    Authors: Margarida Maia, Astrid DeVriese, Tom Janssens, Michaël Moons, Rik J Lories, Jan Tavernier and Edward M Conway
    Citation: BMC Cancer 2011 11:162
    Content type: Research article Published on:

  6. Aquaporins (AQPs) have been recognized to promote tumor progression, invasion, and metastasis and are therefore recognized as promising targets for novel anti-cancer therapies. Potentially relevant AQPs in dis...

    Authors: Arne Warth, Thomas Muley, Michael Meister, Esther Herpel, Anita Pathil, Hans Hoffmann, Philipp A Schnabel, Christian Bender, Andreas Buness, Peter Schirmacher and Ruprecht Kuner
    Citation: BMC Cancer 2011 11:161
    Content type: Research article Published on:

  7. Childhood cancer differs from most common adult cancers, suggesting a distinct aetiology for some types of childhood cancer. Our objective in this study was to test the difference in incidence rates of 4 non-C...

    Authors: Beatriz de Camargo, Juliana Moreira de Oliveira Ferreira, Rejane de Souza Reis, Sima Ferman, Marceli de Oliveira Santos and Maria S Pombo-de-Oliveira
    Citation: BMC Cancer 2011 11:160
    Content type: Research article Published on:

  8. Criteria for admitting patients with incurable diseases to the medical intensive care unit (MICU) remain unclear and have ethical implications.

    Authors: Claire Andréjak, Nicolas Terzi, Stéphanie Thielen, Emmanuel Bergot, Gérard Zalcman, Pierre Charbonneau and Vincent Jounieaux
    Citation: BMC Cancer 2011 11:159
    Content type: Research article Published on:

  9. Some breast cancer patients receiving anti-angiogenic treatment show increased metastases, possibly as a result of induced hypoxia. The effect of hypoxia on tumor cell migration was assessed in selected lumina...

    Authors: Melanie J Voss, Mischa F Möller, Desmond G Powe, Bernd Niggemann, Kurt S Zänker and Frank Entschladen
    Citation: BMC Cancer 2011 11:158
    Content type: Research article Published on:

  10. The purpose of this study was to assess the feasibility and accuracy of sentinel lymph nodes (SLNs) detection using 99mTc phytate in predicting pelvic lymph nodes status for radical abdominal trachelectomy (RA...

    Authors: Xue-lian Du, Xiu-gui Sheng, Tao Jiang, Qing-shui Li, Hao Yu, Chun-xia Pan, Chun-hua Lu, Cong Wang and Qu-qing Song
    Citation: BMC Cancer 2011 11:157
    Content type: Research article Published on:

  11. The use of radiotherapy in osteosarcoma (OS) is controversial due to its radioresistance. OS patients currently treated with radiotherapy generally are inoperable, have painful skeletal metastases, refuse surg...

    Authors: Jantine PosthumaDeBoer, Thomas Würdinger, Harm CA Graat, Victor W van Beusechem, Marco N Helder, Barend J van Royen and Gertjan JL Kaspers
    Citation: BMC Cancer 2011 11:156
    Content type: Research article Published on:

  12. Women with a personal history of breast cancer have a high risk of developing an ipsi- or contralateral recurrence. We aimed to compare the growth rate of primary breast cancer and recurrences in women who had...

    Authors: Ingrid Millet, Emmanuelle Bouic-Pages, Denis Hoa, David Azria and Patrice Taourel
    Citation: BMC Cancer 2011 11:155
    Content type: Research article Published on:

  13. Maslinic acid, a pentacyclic triterpene found in the protective wax-like coating of the leaves and fruit of Olea europaea L., is a promising agent for the prevention of colon cancer. We have shown elsewhere that ...

    Authors: Fernando J Reyes-Zurita, Gisela Pachón-Peña, Daneida Lizárraga, Eva E Rufino-Palomares, Marta Cascante and José A Lupiáñez
    Citation: BMC Cancer 2011 11:154
    Content type: Research article Published on:

  14. NSAIDs exhibit protective properties towards some cancers, especially colon cancer. Yet, it is not clear how they play their protective role. PGE2 is generally shown as the only target of the NSAIDs anticancerous...

    Authors: Lisenn Lalier, François Pedelaborde, Christophe Braud, Jean Menanteau, François M Vallette and Christophe Olivier
    Citation: BMC Cancer 2011 11:153
    Content type: Research article Published on:

  15. Authors: Juliana G Assumpção, Ana Luíza Seidinger, Maria José Mastellato, Raul C Ribeiro, Gerard P Zambetti, Ramapriya Ganti, Kumar Srivastava, Sheila Shurtleff, Deqing Pei, Luiz Carlos Zeferino, Rozany M Dufloth, Silvia Regina Brandalise and José Andres Yunes
    Citation: BMC Cancer 2011 11:152
    Content type: Erratum Published on:

    The original article was published in BMC Cancer 2008 8:357

  17. Hepatocellular carcinoma (HCC) usually has a dismal prognosis because of its limited response to current pharmacotherapy and high metastatic rate. Sulfated oligosaccharide has been confirmed as having potent a...

    Authors: Chun-Li Xiao, Zhong-Hua Tao, Lin Guo, Wei-Wei Li, Jin-Liang Wan, Hui-Chuan Sun, Lu Wang, Zhao-You Tang, Jia Fan and Wei-Zhong Wu
    Citation: BMC Cancer 2011 11:150
    Content type: Research article Published on:

  18. Breast cancer is a collection of diseases in which molecular phenotypes can act as both indicators and mediators of therapeutic strategy. Therefore, candidate therapeutics must be assessed in the context of mu...

    Authors: Jeffrey D Altenburg, Andrew A Bieberich, Colin Terry, Kevin A Harvey, Justin F VanHorn, Zhidong Xu, V Jo Davisson and Rafat A Siddiqui
    Citation: BMC Cancer 2011 11:149
    Content type: Research article Published on:

  19. Despite the recent publication of results from two randomized clinical trials, prostate specific antigen (PSA) screening for prostate cancer remains a controversial issue. There is lack of agreement across stu...

    Authors: David C Wheeler, Konrad M Szymanski, Amanda Black and David E Nelson
    Citation: BMC Cancer 2011 11:148
    Content type: Debate Published on:

  22. Geographical variations in medical practice are expected to be small when the evidence about the effectiveness and safety of a particular technology is abundant. This would be the case of the prescription of c...

    Authors: Manuel Ridao-López, Sandra García-Armesto, Begoña Abadía-Taira, Salvador Peiró-Moreno and Enrique Bernal-Delgado
    Citation: BMC Cancer 2011 11:145
    Content type: Research article Published on:

  23. Medulloblastoma is the most common brain tumor in children, and its prognosis is worse than for many other common pediatric cancers. Survivors undergoing treatment suffer from serious therapy-related side effe...

    Authors: Seung Joon Lee, Candice Krauthauser, Victoria Maduskuie, Paul T Fawcett, James M Olson and Sigrid A Rajasekaran
    Citation: BMC Cancer 2011 11:144
    Content type: Research article Published on:

  24. Optimizing treatment through microarray-based molecular subtyping is a promising method to address the problem of heterogeneity in breast cancer; however, current application is restricted to prediction of dis...

    Authors: Kuo-Jang Kao, Kai-Ming Chang, Hui-Chi Hsu and Andrew T Huang
    Citation: BMC Cancer 2011 11:143
    Content type: Research article Published on:

  25. Cerebral metastases are a common cause of death in patients with melanoma. Systemic drug treatment of these metastases is rarely effective, and where possible surgical resection and/or stereotactic radiosurger...

    Authors: Gerald Fogarty, Rachael L Morton, Janette Vardy, Anna K Nowak, Catherine Mandel, Peta M Forder, Angela Hong, George Hruby, Bryan Burmeister, Brindha Shivalingam, Haryana Dhillon and John F Thompson
    Citation: BMC Cancer 2011 11:142
    Content type: Study protocol Published on:

    The Update to this article has been published in Trials 2019 20:477

  26. Breast cancer is the leading cause of cancer mortality among women in Malaysia. Delayed diagnosis is preventable and has major effects on patients' prognosis and survival. The objectives of our study were to i...

    Authors: Bachok Norsa'adah, Krishna G Rampal, Mohd A Rahmah, Nyi N Naing and Biswa M Biswal
    Citation: BMC Cancer 2011 11:141
    Content type: Research article Published on:

  27. Today, more than 70% of patients with primary node-negative breast cancer are cured by local therapy alone. Many patients receive overtreatment by adjuvant chemotherapy due to inadequate risk assessment. So fa...

    Authors: Eva J Kantelhardt, Martina Vetter, Marcus Schmidt, Corinne Veyret, Doris Augustin, Volker Hanf, Christoph Meisner, Daniela Paepke, Manfred Schmitt, Fred Sweep, Gunter von Minckwitz, Pierre-Marie Martin, Fritz Jaenicke, Christoph Thomssen and Nadia Harbeck
    Citation: BMC Cancer 2011 11:140
    Content type: Study protocol Published on:

  28. A cross-talk between different receptor tyrosine kinases (RTKs) plays an important role in the pathogenesis of human cancers.

    Authors: Chen-Yun Yeh, Shin-Mei Shin, Hsuan-Heng Yeh, Tsung-Jung Wu, Jyh-Wei Shin, Tsuey-Yu Chang, Giri Raghavaraju, Chung-Ta Lee, Jung-Hsien Chiang, Vincent S Tseng, Yuan-Chii G Lee, Cheng-Huang Shen, Nan-Haw Chow and Hsiao-Sheng Liu
    Citation: BMC Cancer 2011 11:139
    Content type: Research article Published on:

  30. Inactivating mutations of SMAD4 are frequent in metastatic colorectal carcinomas. In previous analyses, we were able to show that restoration of Smad4 expression in Smad4-deficient SW480 human colon carcinoma ...

    Authors: Sven-T Liffers, Abdelouahid Maghnouj, Johanna B Munding, René Jackstadt, Ulrike Herbrand, Thomas Schulenborg, Katrin Marcus, Susanne Klein-Scory, Wolff Schmiegel, Irmgard Schwarte-Waldhoff, Helmut E Meyer, Kai Stühler and Stephan A Hahn
    Citation: BMC Cancer 2011 11:137
    Content type: Research article Published on:

  31. Medulloblastoma is a highly malignant pediatric brain tumor that requires surgery, whole brain and spine irradiation, and intense chemotherapy for treatment. A more sophisticated understanding of the pathophys...

    Authors: Susan E Spiller, Naomi J Logsdon, Lindsey A Deckard and Harald Sontheimer
    Citation: BMC Cancer 2011 11:136
    Content type: Research article Published on:

  32. The standard treatment for patients with advanced transitional cell carcinoma of the bladder is platin based chemotherapy. Only approximately 50% of the patients respond to chemotherapy. Therefore, molecular p...

    Authors: Iver Nordentoft, Lars Dyrskjøt, Julie S Bødker, Peter J Wild, Arndt Hartmann, Simone Bertz, Jan Lehmann, Torben F Ørntoft and Karin Birkenkamp-Demtroder
    Citation: BMC Cancer 2011 11:135
    Content type: Research article Published on:

  33. The efficiencies of T cell based immunotherapies are affected by insufficient migration and activation of tumor specific effector T cells in the tumor. Accumulating evidence exists on the ability of ionizing r...

    Authors: Carmen Timke, Hubertus Schmitz Winnenthal, Felix Klug, Falk FF Roeder, Andreas Bonertz, Christoph Reissfelder, Nathalie Rochet, Moritz Koch, Christine Tjaden, Markus W Buechler, Juergen Debus, Jens Werner, Philipp Beckhove, Jürgen Weitz and Peter E Huber
    Citation: BMC Cancer 2011 11:134
    Content type: Study protocol Published on:

  35. There are large ethnic differences in cervical cancer survival in New Zealand that are only partly explained by stage at diagnosis. We investigated the association of comorbidity with cervical cancer survival,...

    Authors: Naomi Brewer, Barry Borman, Diana Sarfati, Mona Jeffreys, Steven T Fleming, Soo Cheng and Neil Pearce
    Citation: BMC Cancer 2011 11:132
    Content type: Research article Published on:

  36. Chemotherapy dose delay and/or reduction lower relative total dose intensity (RTDI) and may affect short- and long-term outcome of metastatic breast cancer (MBC) patients.

    Authors: Sibylle Loibl, Tomas Skacel, Valentina Nekljudova, Hans Joachim Lück, Matthias Schwenkglenks, Thomas Brodowicz, Christoph Zielinski and Gunter von Minckwitz
    Citation: BMC Cancer 2011 11:131
    Content type: Research article Published on:

  37. The inflammatory chemokines CCL2 (MCP-1) & CCL5 (RANTES) and the inflammatory cytokines TNFα & IL-1β were shown to contribute to breast cancer development and metastasis. In this study, we wished to determine ...

    Authors: Gali Soria, Maya Ofri-Shahak, Ilana Haas, Neora Yaal-Hahoshen, Leonor Leider-Trejo, Tal Leibovich-Rivkin, Polina Weitzenfeld, Tsipi Meshel, Esther Shabtai, Mordechai Gutman and Adit Ben-Baruch
    Citation: BMC Cancer 2011 11:130
    Content type: Research article Published on:

  38. Oral (p.o.) chemotherapy treatments gained increasing importance in the palliative treatment of metastatic breast cancer (MBC). Aim of this survey was to evaluate the acceptance of p.o. treatment and patients'...

    Authors: Sarah Schott, Andreas Schneeweiss, Judith Reinhardt, Thomas Bruckner, Christoph Domschke, Christof Sohn and Michael H Eichbaum
    Citation: BMC Cancer 2011 11:129
    Content type: Research article Published on:

  39. With the advances in modern radiotherapy (RT), many patients with head and neck cancer (HNC) can be effectively cured, and their health-related quality of life (HR-QoL) has become an important issue. In this s...

    Authors: Stephen Wan Leung, Tsair-Fwu Lee, Chih-Yen Chien, Pei-Ju Chao, Wen-Ling Tsai and Fu-Min Fang
    Citation: BMC Cancer 2011 11:128
    Content type: Research article Published on:

  40. Peritumoral edema is a characteristic feature of malignant glioma related to the extent of neovascularisation and to vascular endothelial growth factor (VEGF) expression.

    Authors: Clemens Seidel, Nils Dörner, Matthias Osswald, Antje Wick, Michael Platten, Martin Bendszus and Wolfgang Wick
    Citation: BMC Cancer 2011 11:127
    Content type: Research article Published on:

  41. Mortality is high in patients with esophageal carcinoma as tumors are rarely detected before the disease has progressed to an advanced stage. Here, we sought to isolate cell-free DNA released into the plasma o...

    Authors: Immacolata Andolfo, Giuseppe Petrosino, Loredana Vecchione, Pasqualino De Antonellis, Mario Capasso, Donatella Montanaro, Marica Gemei, Giancarlo Troncone, Achille Iolascon, Michele Orditura, Fortunato Ciardiello, Fernando De Vita and Massimo Zollo
    Citation: BMC Cancer 2011 11:126
    Content type: Research article Published on:

  42. We have previously demonstrated that both canine and human OSA cell lines, as well as 8 fresh canine OSA tumor samples, exhibit constitutive phosphorylation of STAT3, and that this correlates with enhanced exp...

    Authors: Stacey L Fossey, Misty D Bear, William C Kisseberth, Michael Pennell and Cheryl A London
    Citation: BMC Cancer 2011 11:125
    Content type: Research article Published on:

  43. Chemotherapy for glioblastoma (GBM) patients is compromised in part by poor perfusion in the tumor. The present study evaluates how treatment with liposomal formulation of irinotecan (Irinophore Câ„¢), and other...

    Authors: Maite Verreault, Dita Strutt, Dana Masin, Malathi Anantha, Andrew Yung, Piotr Kozlowski, Dawn Waterhouse, Marcel B Bally and Donald T Yapp
    Citation: BMC Cancer 2011 11:124
    Content type: Research article Published on:

  44. The PTEN tumour suppressor gene and PIK3CA proto-oncogene encode proteins which contribute to regulation and propagation of signal transduction through the PI3K/AKT signalling pathway. This study investigates the...

    Authors: Adam Naguib, James C Cooke, Lisa Happerfield, Lucy Kerr, Laura J Gay, Robert N Luben, Richard Y Ball, Panagiota N Mitrou, Alison McTaggart and Mark J Arends
    Citation: BMC Cancer 2011 11:123
    Content type: Research article Published on:

  45. Phosphatase of regenerating liver-3 (PRL-3) has deserved attention as a crucial molecule in the multiple steps of metastasis. In the present study, we examined the mechanisms regulating PRL-3 expression, and a...

    Authors: Akira Ooki, Keishi Yamashita, Shiro Kikuchi, Shinichi Sakuramoto, Natsuya Katada, Mina Waraya, Hiroshi Kawamata, Hiroshi Nishimiya, Kazunori Nakamura and Masahiko Watanabe
    Citation: BMC Cancer 2011 11:122
    Content type: Research article Published on:

  46. Latexin, also known as endogenous carboxypeptidase inhibitor (CPI), has been found to inhibit mouse stem cell populations and lymphoma cell proliferation, demonstrating its potential role as a tumor suppressor...

    Authors: Yong Li, Zhuoma Basang, Huirong Ding, Zheming Lu, Tao Ning, Haoran Wei, Hong Cai and Yang Ke
    Citation: BMC Cancer 2011 11:121
    Content type: Research article Published on:

  47. Chondrosarcoma is virtually resistant to chemotherapy and radiation therapy. Survivin, the smallest member of the inhibitor of apoptosis protein family, is a critical factor for tumor progression and resistanc...

    Authors: Philipp Lechler, Tobias Renkawitz, Valentina Campean, Sanjeevi Balakrishnan, Markus Tingart, Joachim Grifka and Jens Schaumburger
    Citation: BMC Cancer 2011 11:120
    Content type: Research article Published on:

  48. KLK15 over-expression is reported to be a significant predictor of reduced progression-free survival and overall survival in ovarian cancer. Our aim was to analyse the KLK15 gene for putative functional single n...

    Authors: Jyotsna Batra, Christina M Nagle, Tracy O'Mara, Melanie Higgins, Ying Dong, Olivia L Tan, Felicity Lose, Lene Marie Skeie, Srilakshmi Srinivasan, Kelly L Bolton, Honglin Song, Susan J Ramus, Simon A Gayther, Paul DP Pharoah, Mary-Anne Kedda, Amanda B Spurdle…
    Citation: BMC Cancer 2011 11:119
    Content type: Research article Published on:

  49. In patients with advanced hepatocellular carcinoma (HCC), combination chemotherapy using 5- fluorouracil, cisplatin, and mitoxantrone (FMP) could achieve a response rate > 20%, but the beneficial effect was co...

    Authors: Chau-Ting Yeh, Hui-Chin Chen, Chang-Mu Sung, Cheng-Lung Hsu, Chen-Chun Lin, Kuang-Tse Pan, Jeng-Hwei Tseng and Chien-Fu Hung
    Citation: BMC Cancer 2011 11:117
    Content type: Research article Published on:

  50. Many adjuvant trials have been undertaken in an attempt to reduce the risk of recurrence among patients who undergo surgical resection for locally advanced renal cancer. However, no clear benefit has been iden...

    Authors: Adolfo JO Scherr, Joao Paulo SN Lima, Emma C Sasse, Carmen SP Lima and André D Sasse
    Citation: BMC Cancer 2011 11:115
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us